Ceres Nanosciences, Inc.-Product Pipeline Analysis, 2016 Update

Ceres Nanosciences, Inc.-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME321577PD
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Ceres Nanosciences, Inc. (Ceres Nanosciences) is a biotechnology company that offers development of nanotechnology for laboratory research and diagnostics platforms. The company conducts research, develops, and commercializes sample preparation products and diagnostic tests. It provides Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any existing downstream measurement and analysis process. Ceres Nanosciences' Nanotrap High sensitivity lyme antigen test uses the Nanotrap technology to directly measure Lyme antigens in urine. The company operates with product pipeline of sample collection technologies and diagnostics, funded through federal agency grants and industry collaboration funding. Ceres Nanosciences is headquartered in Manassas, Virginia, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Ceres Nanosciences, Inc.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

Ceres Nanosciences, Inc. Company Overview 7

Ceres Nanosciences, Inc. Company Snapshot 7

Ceres Nanosciences, Inc. Pipeline Products and Clinical Trials Overview 8

Ceres Nanosciences, Inc.-Pipeline Analysis Overview 11

Key Facts 11

Ceres Nanosciences, Inc.-Major Products and Services 12

Ceres Nanosciences, Inc. Pipeline Products by Development Stage 13

Ceres Nanosciences, Inc. Pipeline Products Overview 15

Cancer Biomarker Serum Test 15

Cancer Biomarker Serum Test Product Overview 15

Chagas Disease Antigen Test 16

Chagas Disease Antigen Test Product Overview 16

Dengue Virus Test 17

Dengue Virus Test Product Overview 17

Melanoma Skin Patch Sweat Test 18

Melanoma Skin Patch Sweat Test Product Overview 18

Nanotrap Breast Cancer Biomarker Test 19

Nanotrap Breast Cancer Biomarker Test Product Overview 19

Nanotrap Collection Device-Blood 20

Nanotrap Collection Device-Blood Product Overview 20

Nanotrap Collection Device-Saliva 21

Nanotrap Collection Device-Saliva Product Overview 21

Nanotrap Collection Device-Urine 22

Nanotrap Collection Device-Urine Product Overview 22

Nanotrap Colon Cancer Biomarker Test 23

Nanotrap Colon Cancer Biomarker Test Product Overview 23

Nanotrap Human Growth Hormone Test 24

Nanotrap Human Growth Hormone Test Product Overview 24

Nanotrap Lung Cancer Biomarker Test 25

Nanotrap Lung Cancer Biomarker Test Product Overview 25

Nanotrap Malaria Test 26

Nanotrap Malaria Test Product Overview 26

Nanotrap Ovarian Cancer Biomarker Test 27

Nanotrap Ovarian Cancer Biomarker Test Product Overview 27

Nanotrap Prostate Cancer Biomarker Test 28

Nanotrap Prostate Cancer Biomarker Test Product Overview 28

NanoTrap Rift Valley Fever Virus Test 29

NanoTrap Rift Valley Fever Virus Test Product Overview 29

Nanotrap Saliva Screening Test-Ebola 30

Nanotrap Saliva Screening Test-Ebola Product Overview 30

Nanotrap Sarcoma Biomarker Test 31

Nanotrap Sarcoma Biomarker Test Product Overview 31

Nanotrap Traumatic Brain Assessment Test 32

Nanotrap Traumatic Brain Assessment Test Product Overview 32

Nanotrap Tuberculosis Test 33

Nanotrap Tuberculosis Test Product Overview 33

Respiratory Viral Infections Test 34

Respiratory Viral Infections Test Product Overview 34

Ceres Nanosciences, Inc.-Key Competitors 35

Ceres Nanosciences, Inc.-Key Employees 36

Ceres Nanosciences, Inc.-Locations And Subsidiaries 37

Head Office 37

Recent Developments 38

Ceres Nanosciences, Inc., Recent Developments 38

Dec 02, 2014: Ceres Partners with Mason to Develop Saliva Screening Test for Ebola 38

May 24, 2011: Ceres Nanosciences Announces Issuance Of Two Patents 38

Feb 22, 2011: Ceres Nanosciences awarded funding to develop universal sample preparation tool for rift valley fever virus 38

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

Ceres Nanosciences, Inc. Pipeline Products by Equipment Type 9

Ceres Nanosciences, Inc. Pipeline Products by Development Stage 13

List of Tables

Ceres Nanosciences, Inc. Pipeline Products and Clinical Trials Overview 8

Ceres Nanosciences, Inc. Pipeline Products by Equipment Type 8

Ceres Nanosciences, Inc. Pipeline Products by Indication 10

Ceres Nanosciences, Inc., Key Facts 11

Ceres Nanosciences, Inc., Major Products and Services 12

Ceres Nanosciences, Inc. Number of Pipeline Products by Development Stage 13

Ceres Nanosciences, Inc. Pipeline Products Summary by Development Stage 14

Cancer Biomarker Serum Test-Product Status 15

Cancer Biomarker Serum Test-Product Description 15

Chagas Disease Antigen Test-Product Status 16

Chagas Disease Antigen Test-Product Description 16

Dengue Virus Test-Product Status 17

Dengue Virus Test-Product Description 17

Melanoma Skin Patch Sweat Test-Product Status 18

Melanoma Skin Patch Sweat Test-Product Description 18

Nanotrap Breast Cancer Biomarker Test-Product Status 19

Nanotrap Breast Cancer Biomarker Test-Product Description 19

Nanotrap Collection Device-Blood-Product Status 20

Nanotrap Collection Device-Blood-Product Description 20

Nanotrap Collection Device-Saliva-Product Status 21

Nanotrap Collection Device-Saliva-Product Description 21

Nanotrap Collection Device-Urine-Product Status 22

Nanotrap Collection Device-Urine-Product Description 22

Nanotrap Colon Cancer Biomarker Test-Product Status 23

Nanotrap Colon Cancer Biomarker Test-Product Description 23

Nanotrap Human Growth Hormone Test-Product Status 24

Nanotrap Human Growth Hormone Test-Product Description 24

Nanotrap Lung Cancer Biomarker Test-Product Status 25

Nanotrap Lung Cancer Biomarker Test-Product Description 25

Nanotrap Malaria Test-Product Status 26

Nanotrap Malaria Test-Product Description 26

Nanotrap Ovarian Cancer Biomarker Test-Product Status 27

Nanotrap Ovarian Cancer Biomarker Test-Product Description 27

Nanotrap Prostate Cancer Biomarker Test-Product Status 28

Nanotrap Prostate Cancer Biomarker Test-Product Description 28

NanoTrap Rift Valley Fever Virus Test-Product Status 29

NanoTrap Rift Valley Fever Virus Test-Product Description 29

Nanotrap Saliva Screening Test-Ebola-Product Status 30

Nanotrap Saliva Screening Test-Ebola-Product Description 30

Nanotrap Sarcoma Biomarker Test-Product Status 31

Nanotrap Sarcoma Biomarker Test-Product Description 31

Nanotrap Traumatic Brain Assessment Test-Product Status 32

Nanotrap Traumatic Brain Assessment Test-Product Description 32

Nanotrap Tuberculosis Test-Product Status 33

Nanotrap Tuberculosis Test-Product Description 33

Respiratory Viral Infections Test-Product Status 34

Respiratory Viral Infections Test-Product Description 34

Ceres Nanosciences, Inc., Key Employees 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Ceres Nanosciences, Inc., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 54413
Site License
USD 1500 INR 108825
Corporate User License
USD 2250 INR 163238

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com